CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 731656-731827
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"The 2-4-6 pyridostigmine induction regimen is well tolerated and effective in MG. (This work was supported by an unrestricted research grant from Valeant Pharmaceuticals).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T70528","span":{"begin":0,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T70528","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T136","span":{"begin":0,"end":171},"obj":"Sentence"}],"attributes":[{"subj":"T136","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4580","span":{"begin":78,"end":80},"obj":"Disease"},{"id":"T79623","span":{"begin":78,"end":80},"obj":"Disease"}],"attributes":[{"id":"A4580","pred":"mondo_id","subj":"T4580","obj":"http://purl.obolibrary.org/obo/MONDO_0009688"},{"id":"A93805","pred":"mondo_id","subj":"T79623","obj":"http://purl.obolibrary.org/obo/MONDO_0009688"},{"subj":"T4580","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T79623","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93ac"},{"id":"CORD-19-PD-MONDO","color":"#93c6ec"}]}]}}